GLP-1 medicine for PCOS in teens with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a medicine called a GLP-1 agonist (like semaglutide) can help with hormone and ovulation problems in adolescent girls with PCOS and obesity. It aims to improve irregular periods and other PCOS symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with PCOS by specific medical criteria (irregular periods and high testosterone)
- Aged 12 to 18 and at least 2 years since your first period
- Obesity (BMI at or above the 95th percentile for your age)
- PCOS symptoms persist after trying lifestyle changes (diet, exercise) for at least 4 months
- Not pregnant and not planning to become pregnant during the trial
- Not using certain other hormone treatments or diabetes medicines for at least 6 weeks before starting
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a GLP-1 medication (a type of diabetes drug that also helps with weight loss) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial might be an option for you.
This study tests if a GLP-1 medicine (a type of diabetes drug that also helps with weight) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial may be for you.
This Phase 3 study tests whether semaglutide can help people with polycystic ovary syndrome (PCOS) start ovulating and having more regular periods. You may join with or without metformin, and contraception rules are important because the medicine must not be used during pregnancy.
This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.